Don't Skip a Lynch Test to Protect Your Insurance

If you have been offered a test for Lynch syndrome and you are asking whether you should get tested at all because of what it might do to your cover, take this in first: being tested does not change your UK life insurance position. A predictive genetic result — one taken while you have no symptoms of the condition — cannot be asked for on a life insurance application, and you are under no obligation to volunteer it. That is not a soothing generalisation. It is written down, and the words are ones you can hold an insurer to.

The document that protects you is the Code on Genetic Testing and Insurance, an agreement between the UK Government and the Association of British Insurers. Under it, insurers will not ask for, and will not take into account, the result of a predictive genetic test. There is a single narrow exception, and it has nothing to do with bowel or womb cancer. So the worry that a Lynch syndrome test will trail you onto every future insurance form is, in this country, simply mistaken.

The fear is still doing real harm, which is the honest reason this page exists. People put off, or turn down, genetic testing that could add years to their life because they have absorbed advice written for a different country. When the Code was reviewed in 2025, this exact problem — insurance anxiety deterring people from clinically useful testing — was singled out. Skipping the test to protect your insurance is the one move in this whole subject that genuinely costs you something, and it buys you nothing.

The short answer, and the wording behind it

Under the Code on Genetic Testing and Insurance, an insurer will not ask you to take a predictive genetic test, will not ask whether you have taken one, and will not use a predictive result you happen to have. A Lynch syndrome test taken because of family history, before any cancer has appeared, is a predictive test. It falls squarely inside that protection.

The exception people half-remember is real but tightly drawn. The only condition an insurer may ever ask about is Huntington's disease, and only when the total life cover applied for is above £500,000. Below that figure, even Huntington's cannot be asked about. Lynch syndrome does not appear on the approved list at all, at any sum assured. There is no version of the rules under which a life insurer in the UK gets to see your Lynch result and price against it.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance, and its 2025 three-year review, published on gov.uk under the Open Government Licence.

Because the threshold is £500,000 and the exception is one named disease, most applicants never come anywhere near it. If you want to see how rarely the exception can bite for an ordinary policy, we set that out in most life policies never reach the genetic testing threshold.

Why the fear keeps travelling here from abroad

Search this question online and much of what you find is written for the United States, where the position is genuinely different. American federal law restricts the use of genetic information in health insurance and in employment, but it does not restrict it in life insurance, and several states allow life insurers to use predictive results. In that setting, "get cover before you test" is rational advice.

It does not translate. The UK answer rests on a separate agreement, the Code, which specifically covers life insurance and specifically keeps predictive results out of it. Applying the American logic here leads people to delay a test for a reason that has no force in this country. If you have read that you should rush to buy a policy before testing, read our guide to family history, inherited risk and the odds before you act on it — the sequence you have been told to follow was written for a different rulebook.

What a Lynch syndrome test actually looks at

Lynch syndrome is an inherited fault in one of the genes that repair small errors when cells divide. Carrying it raises the lifetime risk of bowel cancer and, in women, womb cancer, and can raise the risk of some other cancers too. It is one of the more common inherited cancer predispositions, and — this is the point that matters clinically — knowing you have it changes what the NHS does for you, in ways that catch cancers early or prevent them.

Testing reaches people by a few routes. The National Institute for Health and Care Excellence recommends that everyone newly diagnosed with bowel cancer is tested for Lynch syndrome, so a diagnosis in a relative can be what surfaces it in a family. Where a person is found to carry it, their first-degree relatives are offered cascade testing through NHS clinical genetics. A strong family history of bowel or womb cancer, even without a known fault, can also lead your GP to refer you.

Source: National Institute for Health and Care Excellence (NICE), guidance on testing strategies for Lynch syndrome, nice.org.uk.

All of that is a predictive test when it is done before you have cancer yourself. It sits inside the Code's protection, exactly like a test for the faults discussed in two generations of breast cancer on the same side of the family or the odds a reader weighs up after a mother's breast cancer at 42.

What is protected, and what is not

This is the distinction that trips people up, so it is worth being precise. The Code protects the genetic test result. It does not put a wall around your whole medical record.

If a Lynch diagnosis leads to regular surveillance colonoscopies, to a polyp being found and removed, to medication, or to risk-reducing surgery, those are ordinary medical facts. If an application asks about investigations, hospital procedures, operations or diagnoses — and most do — those questions must be answered accurately. The gene result stays off the form; the clinical care that followed it does not.

That sounds like a loophole and it is not. An insurer cannot start from your care and reason backwards to demand the test result. It can only ask the medical questions it asks everyone, and you answer them about what has actually happened to your body. Being under surveillance is not, in itself, the same as being ill, and a colonoscopy that found nothing is a reassuring fact rather than a damaging one. What matters is that you answer honestly what you are asked and do not volunteer the predictive result you are entitled to keep.

The duty on you when you fill in a form is to take reasonable care not to misrepresent the facts you are asked for. That comes from the Consumer Insurance (Disclosure and Representations) Act 2012, and it is a duty to answer the actual questions carefully, not a duty to hand over everything you happen to know. If the form asks whether you have had a colonoscopy in the last five years, you say so. If it does not ask, you are not required to bring it up. And nowhere in that duty is there any room for an insurer to ask for the predictive gene result the Code keeps off the table.

The one thing that genuinely costs you: not testing

Here is where the fear does its damage. A person who declines a Lynch test to protect an insurance policy they may never buy gives up something concrete: entry into a surveillance programme that finds bowel cancers early, when they are far more treatable, and can remove pre-cancerous growths before they ever become cancer. In exchange they protect a policy against a risk that, under the Code, does not exist.

Put concretely, surveillance for someone with Lynch syndrome usually means a colonoscopy every couple of years, sometimes with medication and a conversation about risk-reducing options. A colonoscopy can find a polyp and remove it in the same appointment, before it has any chance to turn into cancer. That is the mechanism that shifts the odds, and it only starts once someone knows the syndrome is there to look for. A person who never tests never joins the programme.

The 2025 review of the Code took this seriously enough to act on it, because the evidence that insurance worry deters testing had become hard to ignore. If you are weighing the test against your cover, the honest arithmetic is stark: the test cannot be used against your application, and the surveillance it unlocks is the thing that changes your odds. This is the same lesson that runs through other family-history questions, such as whether a mother's stroke at 52 follows you — the useful move is nearly always to know, act clinically, and let the insurance rules do their job.

How this works across the UK

The Code on Genetic Testing and Insurance is a UK-wide agreement, so the insurance protection is the same whether you live in England, Scotland, Wales or Northern Ireland. A predictive Lynch result is off the application in all four nations.

What differs is the NHS testing and genetics pathway. Referral criteria and the way clinical genetics services are organised are set nation by nation, so the route your GP uses in Scotland or Northern Ireland may not match the one described for England, even though the underlying aim — testing people newly diagnosed with bowel cancer and cascading to relatives — is broadly shared. If you are told a test is available to you, that offer is about your clinical care; it does not change the insurance position at all.

If you want cover in place anyway

Wanting life insurance sorted is entirely reasonable, and nothing about a Lynch test needs to hold it up. Because the predictive result cannot be asked for, there is no advantage to racing to buy a policy before you test and no penalty for testing first. You can apply when it suits you.

What an application will ask about is the ordinary picture: your age, whether you smoke, your height and weight, your own medical history, and your family history of certain conditions, which insurers are allowed to ask about at any level of cover. When you are ready, you can get life insurance quotes and let an FCA-authorised broker work through those questions with you against your actual circumstances. If motor neurone disease or another inherited condition also runs in your family, the same principles apply — we look at one such case in motor neurone disease in the family and the benefit inside a life policy.

Frequently asked questions

Will a Lynch syndrome test affect my life insurance in the UK?

No. A predictive test result, taken when you have no symptoms, cannot be asked for on a UK life insurance application. Under the Code on Genetic Testing and Insurance, Huntington's disease is the only condition insurers may ask about, and only where total life cover exceeds £500,000. Lynch syndrome is not on that list at any level, so testing does not change your insurance position.

Who is offered testing for Lynch syndrome?

NICE recommends that everyone newly diagnosed with bowel cancer is tested for Lynch syndrome, and relatives of someone found to have it are offered cascade testing through NHS clinical genetics. A strong family history of bowel or womb cancer can also lead to a genetics referral through your GP. The exact referral pathway varies between the four UK nations.

Does having Lynch syndrome change what I must disclose?

The gene result stays off the application. What must be disclosed, if asked, is medical fact: symptoms, a diagnosis, colonoscopies and any surgery you have had. That is why the surveillance a Lynch diagnosis leads to can appear on a form even though the test result behind it cannot. Answer honestly what you are asked, and do not volunteer the predictive result you are entitled to keep.